top of page

Biologics CDMO Market, By Type, By Type of Service, By End-use Industry Market - Growth, Future Prospects, Post COVID-19 Scenario 2021 - 2028

Report ID: GMRI0026    |      Published Date: Oct 2021      |        Report Format: PDF
Price :   $3549

Overview of the Biologics CDMO Market

Contract Development and Manufacturing Organizations (CDMOs) primarily support biopharmaceutical companies by tackling key challenges and accelerating both drug development and manufacturing. As the pharmaceutical industry continues to expand, the demand for CDMO services has grown substantially. This surge, particularly in the biologics CDMO segment, is driven by advancements in technology that have streamlined the processes of drug development and production.

Furthermore, strategic collaborations between companies are enabling broader service capabilities, catering to both small and large pharmaceutical firms. These partnerships aim to enhance efficiency in research and manufacturing timelines, further propelling market growth throughout the forecast period.

The COVID-19 pandemic has also played a significant role in boosting the market. The urgent global demand for vaccines led many biopharmaceutical companies to partner with CDMOs to expedite vaccine development and achieve cost-effective manufacturing. Looking ahead, the need for CDMO services is projected to remain robust, especially with the emergence of new viral and bacterial infections.

Market Segmentation

The global biologics CDMO market is segmented by type, service offering, and end-user industry:

  • By Type:

    • Plant-based

    • Microbial & Mammalian-based

  • By Service Type:

    • Development Services

    • Manufacturing Services

  • By End-Use Industry:

    • Large Pharmaceutical Companies (Big Pharma)

    • Small Pharmaceutical Companies (Small Pharma)

    • Generic Drug Manufacturers

    • Others

Key Market Players

Notable companies operating in the global biologics CDMO space include:

  • Lonza Group AG

  • Boehringer Ingelheim BioXcellence

  • Thermo Fisher Scientific

  • Samsung BioLogics

  • AGC Biologics, Inc.

  • Catalent, Inc.

  • Wuxi Biologics

  • Medicago Inc.

  • iBio Inc.

  • Protalix-Pfizer

  • Mapp Biopharmaceutical – Leaf Bio

  • Ventria Bioscience

  • Kentucky BioProcessing, Inc.

  • PhycoBiologics, Inc.

  • Synthon International Holding B.V.

  • Fraunhofer

  • Icon Genetics GmbH

These organizations play a crucial role in driving the growth of the biologics CDMO market by offering innovative and scalable solutions.

In 2020, the microbial and mammalian-based segment accounted for the largest share of the global biologics CDMO market. These two expression systems are widely used for the production of vaccines and various other biologic drugs. Their dominance is primarily due to the broad availability of vector systems and their high compatibility with human physiology, making them ideal for safe and effective biologics development.

Global Biologics CDMO Market, By Type of Service

Based on service type, the global biologics CDMO market is divided into:

  • Development Services

  • Manufacturing Services

This classification highlights the two core functional areas in which CDMOs support biopharmaceutical companies—ranging from early-stage drug development to large-scale commercial manufacturing.

In 2020, the manufacturing services segment dominated the global biologics CDMO market in terms of revenue share. This can be largely attributed to the growing reliance of small-scale pharmaceutical companies on CDMOs to provide cost-effective, scalable, and efficient manufacturing solutions. These companies often lack in-house infrastructure and expertise, making outsourcing a strategic choice for accelerating production while maintaining quality and compliance standards.

Global Biologics CDMO Market, By End-Use Industry

Based on end-use industry, the global biologics CDMO market is segmented into:

  • Big Pharma

  • Small Pharma

  • Generic Pharma

  • Others

In 2020, the small pharma segment captured the largest share of the global biologics CDMO market. This growth is primarily driven by the increasing demand for efficient drug discovery and streamlined manufacturing processes among smaller pharmaceutical firms. These companies often face limitations in terms of internal R&D infrastructure and production capabilities, prompting them to outsource to CDMOs for access to advanced technologies and cost-effective solutions.

Global Biologics CDMO Market, By Geography

The biologics CDMO market is geographically segmented as follows:

  • North America

    • United States

    • Canada

  • Europe

    • United Kingdom

    • Germany

    • France

    • Rest of Europe

  • Asia Pacific

    • China

    • Japan

    • India

    • Rest of Asia Pacific

  • Latin America

    • Mexico

    • Brazil

    • Rest of Latin America

  • Middle East and Africa (MEA)

    • GCC Countries

    • South Africa

    • Rest of MEA

This geographic segmentation allows for the assessment of regional trends, market drivers, and growth opportunities across both developed and emerging markets.

In 2020, North America accounted for the largest share of the global biologics CDMO market. This dominance is mainly driven by substantial investments in pharmaceutical research, the strong presence of leading CDMO companies, and a well-established pharmaceutical industry across the region. The combination of these factors has created a robust ecosystem for biologics development and manufacturing.

Conversely, the Asia Pacific region is projected to witness significant growth in the coming years. The rising number of CDMO facilities in countries like India and China, coupled with lower operational costs and expanding pharmaceutical capabilities, is expected to accelerate market expansion in this region throughout the forecast period.

AI and Machine Learning Integration, American Marketing Association (AMA), Associate Consultant, Associate Partner (Consulting), Brand Awareness/Perception Studies, Branding Research, Case Studies, Competitor Analysis, Competitor Research, Comprehensive Approach, Consultant, Consulting/Consultancy, Consistency and Brand Alignment, Cost-Effectiveness, Council of American Survey Research (CASRO), Customer Journey Maps (CJM), Customer Research, Customer Understanding, Data Analysis, Data Collection, Digital Transformation Consulting, Director of Market Research, Economic Consulting, Efficiency, Enhanced Decision-Making, ESG (Environmental, Social, Governance) Consulting, ESOMAR, Exploratory Research, Financial Advisory, Flexible Models and Specialization (Consulting), Human Element (Consulting), Human Resources (HR) Consulting, Implementation Consulting, In-house Market Research Capabilities, Insights Analyst, Insights Generation, Integrated Services, Intern (Consulting), IT/Technology Consulting, Manager (Consulting), Market Research, Market Research Analysts, Market Research Reports, Market Segmentation Reports, Marketing Data Analyst, Marketing Research Association (MRA), Observational Research, Optimized Resource Allocation, Partner (Consulting), Personalized Solutions (Consulting), Primary Research, Problem Solving, Product Research, Product Research Analyst, Qualitative Research, Qualitative Research Assistant, Qualitative Research Consultants Association (QRCA), Quantitative Research, Real-Time Data Analytics, Remote Work (Consulting), Risk Consulting, Risk Reduction, Secondary Research, Senior Associate Consultant, Senior Manager (Consulting), Social Media Listening, Specific Research, Strategic Plans, Strategy Consulting, Sustainability Consulting, SWOT Analysis, Target Market/Audience.

bottom of page